{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:43:04Z","timestamp":1790739784660,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute of Pharmacology PAS, Krak\u00f3w","award":["POIG.01.01.02-12-004\/09-00"],"award-info":[{"award-number":["POIG.01.01.02-12-004\/09-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.pnpbp.2012.05.015","type":"journal-article","created":{"date-parts":[[2012,5,29]],"date-time":"2012-05-29T10:32:10Z","timestamp":1338287530000},"page":"102-106","source":"Crossref","is-referenced-by-count":24,"title":["Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test"],"prefix":"10.1016","volume":"39","author":[{"given":"Agnieszka","family":"Pa\u0142ucha-Poniewiera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Pilc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.05.015_bb0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.bjp.0703904","article-title":"Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges","volume":"132","author":"Attucci","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0010","doi-asserted-by":"crossref","first-page":"7871","DOI":"10.1523\/JNEUROSCI.20-21-07871.2000","article-title":"Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus","volume":"20","author":"Awad","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.euroneuro.2006.03.002","article-title":"Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests","volume":"17","author":"Belozertseva","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0025","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clinthera.2005.06.015","article-title":"Acamprosate for the treatment of alcohol dependence","volume":"27","author":"Boothby","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0091-3057(92)90210-7","article-title":"Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats","volume":"41","author":"Daoust","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/appi.ajp.2011.09111607","article-title":"Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study","volume":"168","author":"Deschwanden","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.bjp.0703574","article-title":"A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices","volume":"131","author":"Doherty","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0055","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1113\/jphysiol.2008.150722","article-title":"Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome","volume":"586","author":"D\u00f6len","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0060","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s10803-010-0988-9","article-title":"Brief report: acamprosate in fragile X syndrome","volume":"40","author":"Erickson","year":"2010","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0065","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/j.1530-0277.2008.00787.x","article-title":"Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL\/6J mice","volume":"32","author":"Gupta","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0070","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1111\/j.1530-0277.2002.tb02484.x","article-title":"Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors","volume":"26","author":"Harris","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0075","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fbp.0000181600.95405.c7","article-title":"N-methyl-D-aspartate and group I metabotropic glutamate receptors are involved in the expression of ethanol-induced sensitization in mice","volume":"17","author":"Kotlinska","year":"2006","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/alcalc\/agq077","article-title":"Alcohol-use disorders and depression: results from individual patient data meta-analysis of the acamprosate-controlled studies","volume":"46","author":"Lejoyeux","year":"2011","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0090","article-title":"Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study","author":"Lenze","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0095","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1124\/jpet.106.103143","article-title":"Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice","volume":"319","author":"Li","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1530-0277.2008.00690.x","article-title":"Acamprosate: recent findings and future research directions","volume":"32","author":"Mann","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0105","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1530-0277.2002.tb02587.x","article-title":"Acamprosate has no effect on NMDA-induced toxicity but reduces toxicity induced by spermidine or by changing the medium in organotypic hippocampal slice cultures from rat","volume":"26","author":"Mayer","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1530-0277.1998.tb03871.x","article-title":"Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain","volume":"22","author":"Naassila","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2007.04.007","article-title":"Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs","volume":"115","author":"Pa\u0142ucha","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.pbb.2005.06.015","article-title":"Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist","volume":"81","author":"Pa\u0142ucha","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1358\/dnp.1998.11.9.863689","article-title":"Glutamate in CNS disorders as a target for drug development: an update","volume":"11","author":"Parsons","year":"1998","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuropharm.2004.03.004","article-title":"Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network","volume":"47","author":"Pierrefiche","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0028-3908(02)00082-5","article-title":"Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats","volume":"43","author":"Pilc","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(01)00297-4","article-title":"Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons","volume":"106","author":"Pisani","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0145","first-page":"595","article-title":"Activation of the NMDA\/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test","volume":"59","author":"Poleszak","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0150","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S1734-1140(10)70381-9","article-title":"NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice","volume":"62","author":"Pomierny-Chamio\u0142o","year":"2010","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0155","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1345\/aph.1P353","article-title":"Acamprosate calcium as augmentation therapy for anxiety disorders","volume":"44","author":"Schwartz","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(99)00330-1","article-title":"Antidepressants for the new millennium","volume":"375","author":"Skolnick","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"Tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00726-009-0412-y","article-title":"The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test","volume":"39","author":"Szewczyk","year":"2010","journal-title":"Amino Acids"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0175","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczy\u0144ska","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(00)80810-7","article-title":"Coupling of mGluR\/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins","volume":"23","author":"Tu","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0185","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00726-001-0131-5","article-title":"Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats","volume":"23","author":"Wiero\u0144ska","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0190","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0896-6273(00)80588-7","article-title":"Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins","volume":"21","author":"Xiao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0195","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.05.015_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"Zarate","year":"2006","journal-title":"Am J Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T21:15:16Z","timestamp":1713993316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0278584612001170"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.05.015","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}